Back
Franklin Core ETF Portfolio ETF Series Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
22
CBL.TO
Franklin Core ETF Portfolio ETF Series
Last Price:
$23.03
Seasonality Move:
1.78%
Sell
42
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$22.47
Seasonality Move:
10.98%
Sell
22
Franklin Core ETF Portfolio ETF Series (CBL.TO)
is a Sell
Is Franklin Core ETF Portfolio ETF Series a Buy, Sell or Hold?
-
The current Franklin Core ETF Portfolio ETF Series [CBL.TO] share price is $23.39. The Score for CBL.TO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
CBL.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $22.45. The Score for RARE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CBL.TO Stock Price Chart
What is Franklin Core ETF Portfolio ETF Series's stock price today?
-
The Franklin Core ETF Portfolio ETF Series share price today is $23.39The current trend is moderately bullish and CBL.TO is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $22.45The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
CBL.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.18 | Buy |
| Relative Strength Index (14 RSI): | 48.05 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.15 - 23.81) | Sell |
| Bollinger Bands (100): | (23.38 - 23.96) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 56.63 | Buy |
| Chaikin Money Flow: | 1771128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.95 - 22.45) | Buy |
| Bollinger Bands (100): | (20.69 - 32.11) | Sell |
CBL.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.23 | Buy |
| 20-day SMA: | 23.35 | Buy |
| 50-day SMA: | 23.71 | Sell |
| 200-day SMA: | 23.17 | Buy |
| 8-day EMA: | 22.84 | Buy |
| 20-day EMA: | 18.57 | Buy |
| 50-day EMA: | 11 | Buy |
| 200-day EMA: | 3.44 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.23 | Buy |
| 20-day SMA: | 20.91 | Buy |
| 50-day SMA: | 22.29 | Buy |
| 200-day SMA: | 28.87 | Sell |
| 8-day EMA: | 20.84 | Buy |
| 20-day EMA: | 20.98 | Buy |
| 50-day EMA: | 22.54 | Sell |
| 200-day EMA: | 28.72 | Sell |
Franklin Core ETF Portfolio ETF Series Earnings Growth & CBL.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.74 per share, an increase this year of $1.29 per share, and an increase next year of $4.48 per share.
Franklin Core ETF Portfolio ETF Series Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||